The Endocrine Board Review, 18th Edition, is the premier study resource for fellows and clinicians preparing for the endocrinology board exam. Developed for rigorous, self-directed learning, this edition aligns with the blueprint of the American Board of Internal Medicine’s endocrinology, diabetes, and metabolism certification exam.
Featuring more than 220 case-based questions across exam topics, this ebook helps you focus on what matters most to achieve your certification or recertification.
Authored and updated by expert faculty, this edition supports fellows preparing for initial endocrinology board certification, practicing endocrinologists maintaining certification, and international physicians seeking a United States-based endocrinology review.
Your purchase includes access to the eBook versions of Endocrine Board Review, 18th Edition. This resource is certified for 55.0 AMA PRA Category 1 Credits™ and 55 ABIM-MOC points.
All Available Formats |
|
|---|---|
| $169.00 - $259.00 | |
| eBook | $169.00 - $259.00 |
The Endocrine Board Review 18th Edition is a trusted resource designed specifically for endocrinology board certification or recertification. It helps you master key concepts, strengthen clinical expertise, and build confidence for exam day. Ideal for trainees and experienced clinicians, this edition delivers a structured and efficient path to exam readiness.
Earn up to 55 AMA PRA Category 1 Credits™ and 55 ABIM MOC Points. Learn at your own pace while meeting your CME and MOC requirements.
Your purchase includes access to the interactive practice exams in the Endocrine Society’s Center for Learning. Choose from two flexible exam modes to match your study needs.
In Learning Mode, you can answer questions with immediate feedback and detailed explanations that turn every question into a learning opportunity. Earn credit with a minimum score of 70 percent and take advantage of unlimited attempts to track progress and improve weak areas.
In Mock Exam Mode, you can train under timed conditions that mirror the real testing experience. Build customized exams by topic or length, repeat sessions as needed, and build the speed and accuracy required for certification success.
For the most complete endocrinology board certification experience, enroll in Endocrine Board Review (EBR) 2026. The full program includes the hard copy book, the online interactive practice exams, mobile app access, and Live Study Sessions with the expert faculty. Together, these tools provide a focused, efficient path to exam success. Learn more.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates the Endocrine Board Review 2026, 18th Edition, for a maximum of 55 AMA PRA Category 1 Credits™ and 55 points in the ABIM Maintenance of Certification (MOC) program. Successful completion of this CME activity includes participation in the activity evaluation. After completing the activity evaluation, participants will be able to save or print out a CME certificate. The CME activity provider is responsible for submitting participant completion information to the ACCME to grant ABIM MOC points.
CME credits and/or MOC points for the activities related to this material must be claimed by December 31, 2027.
Please note that while other accrediting bodies accept AMA PRA Category 1 Credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
For questions about content or obtaining CME credit, please contact the Endocrine Society at [email protected].
As a provider of CME accredited by the ACCME, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's EBR faculty. There are no commercial supporters of this activity, and no commercial entities have had influence over the planning of this CME activity.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
Irina Bancos, MD, Adrenas, Corcept, Esteve, Recordati, Xeris (Advisory Board); Adaptyx, Astrazeneca, Camurus, Corcept, Crinetics, Diurnal, Esteve, Neurocrine, Recordati, Sparrow Pharmaceutics, Spruce (Consultant); European Journal of Endocrinology (Editor); Esteve, Recordati (Research Support); Dynamed (Reviewer); Elsevier (Writer).
Shagun Bindlish, MD, Golden State Obesity Society (Founder and President), American Diabetes Association journal Clinical Diabetes, Obesity Medicine Association journal Pillars of Medicine (Associate Editor).
John D. Carmichael, MD, American Association of Clinical Endocrinologists and Pituitary Society (Member); Novo Nordisk, Camurus, Xeris (Advisory Board); Crinetics, Novo Nordisk (Research Support).
Marcelo Correia, MD, MSc, PhD, The Obesity Society (Member); Novartis, Eli Lilly, Novo Nordisk, Stead Family (Iowa), National Institutes of Health, PCORI (Research Support); Novo Nordisk (Advisory Board and Consultant); Genentech/Roche (Advisory Board).
Natalie Cusano, MD, MS, Ascendis Pharma, Extend Biosciences (Consultant); Endocrine Practice (Editor); Ascendis Pharma, Takeda/Shire (Research Support); Alexion (Speaker).
Kaniksha Desai, MD, Endocrine Practice (Editor); American Thyroid Association, American Association of Clinical Endocrinologists, Thyroid Disease State Network (Member); Medscape Podcast on Thyroid Diseases (Host).
Hans K. Ghayee, DO, Corcept (Consultant); SDHB Pheo Para Coalition (Funding); University of Texas Southwestern Medical Center (Royalties).
Sangeeta Kashyap, MD, GI Dynamics (Consultant); Fractyl, Inc (Research Support).
E. Michael Lewiecki, MD, Ultragenyx, Angitia (Institutional Research Grants); Amgen, Radius, Kyowa Kirin, Angitia, Ascendis (Consultant); Amgen, Radius, Ascendis, Kyowa Kirin (Speaker).
Cecilia C. Low Wang, MD, American Association of Clinical Endocrinology, American College of Diabetology, American Heart Association, Clinical Diabetes and Endocrinology Institute (Advisory Board); Clinical Diabetes and Endocrinology Institute, Medical Education Resources, Continuing Education Company (Speaker); Dexcom Inc, Virta Health (Research Funding); American Heart Association (Guidelines Committee); FDA Advisory Committee for Endocrinologic Metabolic Drugs (Committee Member).
Elizabeth McAninch, MD, Acella Pharmaceuticals, AbbVie Inc (Consultant); Equilibrate Therapeutics, LLC (Cofounder).
Stephanie Page, MD, PhD, Pharmajor International (Consultant).
The following faculty reported no relevant financial relationships: Dima L. Diab, MD; Margaret Flynn Lippincott, MD; Aniket Sidhaye, MD; and Catherine D. Zhang, MD.
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)
Endocrine Society staff involved in developing content for this activity reported no relevant financial relationships.
Content Licensing
Contact us to learn more about licensing solutions for your organization.
